biokey_8k-121012.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 10, 2012
|
BIO-key International, Inc.
(Exact name of registrant as specified in its charter)
|
|
Delaware
(State or other jurisdiction of
incorporation)
|
1-13463
(Commission File Number)
|
41-1741861
(I.R.S. Employer Identification No.)
|
|
3349 Highway 138, Building D, Suite B
Wall, NJ 07719
(Address of principal executive offices)
|
|
(732) 359-1100
(Registrant’s telephone number, including area code)
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. Other Events.
On December 10, 2012, BIO-key International, Inc. (the “Company”) issued a press release announcing an agreement with Blue Spike to resolve the Litigation, which resulted in a dismissal of all claims asserted in the Litigation (both against and by the Company) with prejudice, which is included as an exhibit to a Current Report on Form 8-K. A copy of the press release issued by the Company on December 10, 2012 is attached as Exhibit 99.
The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
Item 9.01. Financial Statements, Pro Forma Financial Information and Exhibit.
(d) Exhibits
99.1 Press Release, dated December 10, 2012, issued by the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
BIO-KEY INTERNATIONAL, INC.
|
|
| Date: December 17, 2012 |
|
|
|
| |
By:
|
/s/ Cecilia C. Welch |
|
| |
|
Cecilia C. Welch
|
|
| |
|
Chief Financial Officer
|
|
| |
|
|
|
99.1 Press Release, dated December 10, 2012, issued by the Company.